Cell-Based Assay Design for High-Content Screening of Drug Candidates

키워드

참고문헌 (120)

1. Arkin MR, "Assay Guidance Manual" (2004), Bethesda
2. Arkin MR, "Small-molecule inhibitors of protein-protein interactions: progressing towards the dream", Nat. Rev. Drug Discov, 3, pp.301~317 (2004)
3. Arnone MI, "Using reporter genes to study cis-regulatory elements", Methods Cell Biol, 74, pp.621~652 (2004)
4. Aronson JK, "Old drugs - new uses", Br. J. Clin. Pharmacol, 64, pp.563~565 (2007)
5. Ashburn TT, "Drug repositioning: identifying and developing new uses for existing drugs", Nat. Rev. Drug. Discov, 3, pp.673~683 (2004)
6. Aswendt M, "A review of novel optical imaging strategies of the stroke pathology and stem cell therapy in stroke", Front. Cell. Neurosci, 8, pp.226~ (2014)
7. Barrangou R, "Advances in CRISPR-Cas9genome engineering: lessons learned from RNA interference", Nucleic Acids Res, 43, pp.3407~3419 (2015)
8. Boland MV, "A neural network classifier capable of recognizing the patterns of all major subcellular structures in fluorescence microscope images of HeLa cells", Bioinformatics, 17, pp.1213~1223 (2001)
9. Boutros M, "The a rt and design of genet ic screens: RNA interference", Nat. Rev. Genet, 9, pp.554~566 (2008)
10. Bronstein I, "Chemiluminescent and bioluminescent reporter gene assays", Anal. Biochem, 219, pp.169~181 (1994)
11. Campeau E, "RNA interference in mammals:behind the screen", Brief. Funct. Genomics, 10, pp.215~226 (2011)
12. Canton I, "Development of a 3D human in vitro skin co-culture model for detecting irritants in real-time", Biotechnol. Bioeng, 106, pp.794~803 (2010)
13. Celli JP, "An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models", Sci. Rep, 4, pp.3751~ (2014)
14. Chen L, "Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease", Nat. Neurosci, 8, pp.657~663 (2005)
15. Chong CR, "New uses for old drugs", Nature, 448, pp.645~646 (2007)
16. Clemons PA, "Complex phenotypic assays in highthroughput screening", Curr. Opin. Chem. Biol, 8, pp.334~338 (2004)
17. Cong L, "Multiplex genome engineering using CRISPR", Cas systems, 2013, pp.339, 819~823
18. Conrad C, "Automatic identification of subcellular phenotypes on human cell arrays", Genome Res, 14, pp.1130~1136 (2004)
19. Conrad C, "Automated microscopy for high-content RNAi screening", J. Cell Biol, 188, pp.453~461 (2010)
20. Crisman TJ, "Underst anding false p osit ives i n reporter gene assays: in silico chemogenomics approaches to prioritize cell-based HTS data", J. Chem. Inf. Model, 47, pp.1319~1327 (2007)
21. Dhaliwal A, "Transfection in the third dimension", Integr. Biol. (Camb.), 5, pp.1206~1216 (2013)
22. Diamandis P, "Chemical genetics reveals a complex functional ground state of neural stem cells", Nat. Chem. Biol, 3, pp.268~273 (2007)
23. Duryagina R, "Cellular reporter systems for high-throughput screening of interactions between bioactive matrices and human mesenchymal stromal cells", Tissue Eng. Part C Methods, 20, pp.828~837 (2014)
24. Echeverri CJ, "High-throughput RNAi screening in cultured cells: a user’s guide", Nat. Rev. Genet, 7, pp.373~384 (2006)
25. Edwards BS, "Flow cytometry: impact on early drug discovery", J. Biomol. Screen, 20, pp.689~707 (2015)
26. Elliott DA, "NKX2-5(eGFP", w) hESCs for isolation of human cardiac progenitors and cardiomyocytes, 2011, pp.8, 1037~1040
27. Enikolopov G, "Viral and transgenic reporters and genetic analysis of adult neurogenesis", Cold Spring Harb. Perspect. Biol, 7, pp.a018804~ (2015)
28. Erfle H, "Reverse transfection on cell arrays for high content screening microscopy", Nat. Protoc, 2, pp.392~399 (2007)
29. Erfle H, "Work flow for multiplexing siRNA assays by solid-phase reverse transfection in multiwell plates", J. Biomol. Screen, 13, pp.575~580 (2008)
30. Erfle H, "siRNA cell arrays for high-content screening microscopy", Biotechniques, 37, pp.454~458 (2004)
31. Falcon BL, "High-content multiplexed tissue imaging and quantification for cancer drug discovery", Drug Discov. Today, 18, pp.510~522 (2013)
32. Feng Y, "Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds", Nat. Rev. Drug Discov, 8, pp.567~578 (2009)
33. Fernandes TG, "High-throughput cellular microarray platforms:applications in drug discovery, toxicology and stem cell research", Trends Biotechnol, 27, pp.342~349 (2009)
34. Fernandes TG, "On-chip, cell-based microarray immunofluorescence assay for high-throughput analysis of target proteins", Anal. Chem, 80, pp.6633~6639 (2008)
35. Fields S, "A novel genetic system to detect protein-protein interactions", Nature, 340, pp.245~246 (1989)
36. Fishman MC, "Pharmaceuticals: a n ew grammar for drug discovery", Nature, 437, pp.491~493 (2005)
37. Galarneau A, "Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein-protein interactions", Nat. Biotechnol, 20, pp.619~622 (2002)
38. Ganesan AK, "Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells", PLoS Genet, 4, pp.e1000298~ (2008)
39. Gasparri F, "Image-based h igh-cont ent reporter assays: limitations and advantages", Drug Discov. Today Technol, 7, pp.e1~e94 (2010)
40. Genovesio A, "Automated genome-wide visual profiling of cellular proteins involved in HIV infection", J. Biomol. Screen, 16, pp.945~958 (2011)
41. Ghosh I, "Antiparallel leucine zipper-directed protein reassembly: application to the green fluorescent protein", J. Am. Chem. Soc, 122, pp.5658~5659 (2000)
42. Gorbatyuk OS, "The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease", Proc. Natl. Acad. Sci. USA, 105, pp.763~768 (2008)
43. Hamdi A, "Yeast two-hybrid methods and their applications in drug discovery", Trends Pharmacol. Sci, 33, pp.109~118 (2012)
44. Hay M, "Clinical development success rates for investigational drugs", Nat. Biotechnol, 32, pp.40~51 (2014)
45. Haycock JW, "3D cell culture: a review of current approaches and techniques", Methods Mol. Biol, 695, pp.1~15 (2011)
46. Hendriks G, "The ToxTracker assay: novel GFP reporter systems that provide mechanistic insight into the genotoxic properties of chemicals", Toxicol. Sci, 125, pp.285~298 (2012)
47. Hendriks G, "Cellular-signaling pathways unveil the carcinogenic potential of chemicals", J. Appl. Toxicol, 33, pp.399~409 (2013)
48. Herce HD, "Visualization and targeted disruption of protein interactions in living cells", Nat. Commun, 4, pp.2660~ (2013)
49. Hibbitts A, "Screening of siRNA nanoparticles for delivery to airway epithelial cells using high-content analysis", Ther. Deliv, 2, pp.987~999 (2011)
50. Hofman F, "Immunohistochemistry", Curr. Protoc. Immunol. Chapter, 21, pp.Unit 21.4~ (2002)
51. Horvath P, "CRISPR", Cas, the immune system of bacteria and archaea, 2010, pp.327, 167~170
52. Hsu PD, "DNA targeting specificity of RNAguided Cas9 nucleases", Nat. Biotechnol, 31, pp.827~832 (2013)
53. Hughes JP, "Principles of early drug discovery", Br. J. Pharmacol, 162, pp.1239~1249 (2011)
54. Hynds RE, "Concise review: the relevance of human stem cell-derived organoid models for epithelial translational medicine", Stem Cells, 31, pp.417~422 (2013)
55. Inglese J, "High-throughput screening assays for t he ident ification o f chemical probes", Nat. Chem. Biol, 3, pp.466~479 (2007)
56. Jackson AL, "Widespread siRNA “off-target”transcript silencing mediated by seed region sequence complementarity", RNA, 12, pp.1179~1187 (2006)
57. Jinek M, "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity", Science, 337, pp.816~821 (2012)
58. Johnsson N, "Split ubiquitin as a sensor of protein interactions in vivo", Proc. Natl. Acad. Sci. USA, 91, pp.10340~10344 (1994)
59. Karlsson HL, "Mechanism-based genotoxicity screening of metal oxide nanoparticles using the ToxTracker panel of reporter cell lines", Part. Fibre Toxicol, 11, pp.41~ (2014)
60. Korn K, "Cell-based high-content screening of small-molecule libraries", Curr. Opin. Chem. Biol, 11, pp.503~510 (2007)
61. Krausz E., "High-content siRNA screening", Mol. Biosyst, 3, pp.232~240 (2007)
62. Krausz E, "High-cont ent siRNA screening for target identification and validation", Expert Opin. Drug Discov, 3, pp.551~564 (2008)
63. Kumar R, "High-throughput selection of effective RNAi probes for gene silencing", Genome Res, 13, pp.2333~2340 (2003)
64. Kwon SJ, "High-throughput and combinatorial gene expression on a chip for metabolism-induced toxicology screening", Nat. Commun, 5, pp.3739~ (2014)
65. Ledford H, "Translational research: 4 ways to fix the clinical trial", Nature, 477, pp.526~528 (2011)
66. Li X, "Generation of destabilized green fluorescent protein as a transcription reporter", J. Biol. Chem, 273, pp.34970~34975 (1998)
67. Loo LH, "Image-based multivariate profiling of drug responses from single cells", Nat. Methods, 4, pp.445~453 (2007)
68. Machleidt T, "Multiplexing of pathway-specific beta-lactamase reporter gene assays by optical coding with Qtracker nanocrystals", J. Biomol. Screen, 14, pp.845~852 (2009)
69. Mali P, "Cas9 as a versatile tool for engineering biology", Nat. Methods, 10, pp.957~963 (2013)
70. Mali P, "RNA-guided human genome engineering via Cas9", Science, 339, pp.823~826 (2013)
71. Matys V, "TRANSFAC a nd i t s module TRANSCompel: transcriptional gene regulation in eukaryotes", Nucleic Acids Res, 34, pp.D108~D110 (2006)
72. Meacham CE, "Tumour heterogeneity and cancer cell plasticity", Nature, 501, pp.328~337 (2013)
73. Meli L, "Three-dimensional cellular microarray platform for human neural stem cell differentiation and toxicology", Stem Cell Res, 13, pp.36~47 (2014)
74. Michnick SW, "A toolkit of protein-fragment complementation assays for studying and dissecting large-scale and dynamic protein-protein interactions in living cells", Methods Enzymol, 470, pp.335~368 (2010)
75. Michnick SW, "Universal strategies in research and drug discovery based on protein-fragment complementation assays", Nat. Rev. Drug Discov, 6, pp.569~582 (2007)
76. Michnick SW, "Detection of protein-protein interactions by protein fragment complementation strategies", Methods Enzymol, 328, pp.208~230 (2000)
77. Mohr SE, "RNAi screening: new approaches, understandings, and organisms", Wiley Interdiscip. Rev. RNA, 3, pp.145~158 (2012)
78. Mohr SE, "RNAi screening comes of age: improved techniques and complementary approaches", Nat. Rev. Mol. Cell Biol, 15, pp.591~600 (2014)
79. Narayanan K, "Bacterial artificial chromosome mutagenesis using recombineering", J. Biomed. Biotechnol, 2011, pp.971296~ (2011)
80. Naylor LH, "Reporter gene technology: the future looks bright", Biochem. Pharmacol, 58, pp.749~757 (1999)
81. Neumann B, "High-throughput RNAi screening by time-lapse imaging of live human cells", Nat. Methods, 3, pp.385~390 (2006)
82. Ohtsuka M, "Recombinant DNA technologies for construction of precisely designed transgene constructs", Curr. Pharm. Biotechnol, 10, pp.244~251 (2009)
83. Pampaloni F, "The third dimension bridges the gap between cell culture and live tissue", Nat. Rev. Mol. Cell Biol, 8, pp.839~845 (2007)
84. Paul SM, "How t o improve R&D productivity: the pharmaceutical industry’s grand challenge", Nat. Rev. Drug Discov, 9, pp.203~214 (2010)
85. Pawson T, "Protein-protein interactions define specificity in signal transduction", Genes Dev, 14, pp.1027~1047 (2000)
86. Pelkmans L, "Genome-wide analysis of human kinases in clathrin- and caveolae", raft-mediated endocytosis, 2005, pp.436, 78~86
87. Pelletier JN, "Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments", Proc. Natl. Acad. Sci. USA, 95, pp.12141~12146 (1998)
88. Perfetto SP, "Seventeen-colour flow cytometry: unravelling the immune system", Nat. Rev. Immunol, 4, pp.648~655 (2004)
89. Perlman ZE, "Multidimensional drug profiling by automated microscopy", Science, 306, pp.1194~1198 (2004)
90. Rao VS, "Proteinprotein interaction detection: methods and analysis", Int. J. Proteomics, 2014, pp.147648~ (2014)
91. Remy I, "A highly sensitive proteinprotein interaction assay based on Gaussia luciferase", Nat. Methods, 3, pp.977~979 (2006)
92. Remy I, "Erythropoietin receptor activation by a ligand-induced conformation change", Science, 283, pp.990~993 (1999)
93. Ren Q, "A dual-reporter system for real-time monitoring and high-throughput CRISPR", Cas9 library screening of the hepatitis C virus, 2015, pp.5, 8865~
94. Ryan DP, "Protein-protein interactions in human disease", Curr. Opin. Struct. Biol, 15, pp.441~446 (2005)
95. Samsel L, "Imaging flow cytomet ry for morphologic and phenotypic characterization of rare circulating endothelial cells", Cytometry B Clin. Cytom, 84, pp.379~389 (2013)
96. Sato M, "Genetically encoded fluorescent indicators to visualize protein phosphorylation by extracellular signal-regulated kinase in single living cells", Anal. Chem, 79, pp.2570~2575 (2007)
97. Sato M, "Fluorescent indicators for imaging protein phosphorylation in single living cells", Nat. Biotechnol, 20, pp.287~294 (2002)
98. Shalem O, "Genome-scale CRISPR-Cas9knockout screening in human cells", Science, 343, pp.84~87 (2014)
99. Shalem O, "High-throughput functional genomics using CRISPR-Cas9", Nat. Rev. Genet, 16, pp.299~311 (2015)
100. Shaner NC, "Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red f luorescent protein", Nat. Biotechnol, 22, pp.1567~1572 (2004)
101. Silva JM, "RNA interference microarrays: high-throughput loss-offunction genetics in mammalian cells", Proc. Natl. Acad. Sci. USA, 101, pp.6548~6552 (2004)
102. Soderberg O, "Direct observation of individual endogenous protein complexes in situ by proximity ligation", Nat. Methods, 3, pp.995~1000 (2006)
103. Sonnichsen B, "Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans", Nature, 434, pp.462~469 (2005)
104. Sui G, "A DNA vector-based RNAi technology to suppress gene expression in mammalian cells", Proc. Natl. Acad. Sci. USA, 99, pp.5515~5520 (2002)
105. Swinney DC, "How were new medicines discovered", Nat. Rev. Drug Discov, 10, pp.507~519 (2011)
106. Tanaka M, "An unbiased cell morphology-based screen for new, biologically active small molecules", PLoS Biol, 3, pp.e128~ (2005)
107. Ting AY, "Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells", Proc. Natl. Acad. Sci. USA, 98, pp.15003~15008 (2001)
108. Tung YC, "High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array", Analyst, 136, pp.473~478 (2011)
109. Wade M, "High-throughput silencing using the CRISPR-Cas9 system: a review of the benefits and challenges", J. Biomol. Screen, 20, pp.1027~1039 (2015)
110. Walsh DP, "Chemical genetics", Chem. Rev, 106, pp.2476~2530 (2006)
111. Wang N, "Adenovirus-mediated efficient gene transfer into cultured three-dimensional organoids", PLoS One, 9, pp.e93608~ (2014)
112. Wells JA, "Reaching for high-hanging fruit in drug discovery at protein-protein interfaces", Nature, 450, pp.1001~1009 (2007)
113. Weston CR, "Signal transduction: signaling specificity - a complex affair", Science, 292, pp.2439~2440 (2001)
114. Wiedenheft B, "RNAguided genetic silencing systems in bacteria and archaea", Nature, 482, pp.331~338 (2012)
115. Willmann JK, "Molecular imaging in drug development", Nat. Rev. Drug Discov, 7, pp.591~607 (2008)
116. Wink S, "Quantitative high content imaging of cellular adaptive stress response pathways in toxicity for chemical safety assessment", Chem. Res. Toxicol, 27, pp.338~355 (2014)
117. Yang H, "One-step generation of mice carrying reporter and conditional alleles by CRISPR", Cas-mediated genome engineering, 2013, pp.154, 1370~1379
118. Zanella F, "High content screening:seeing is believing", Trends Biotechnol, 28, pp.237~245 (2010)
119. Zhou Y, "High-throughput screening of a CRISPR", Cas9 library for functional genomics in human cells, 2014, pp.509, 487~491
120. Ziauddin J, "Microarrays of cells expressing defined cDNAs", Nature, 411, pp.107~110 (2001)

관련 논문AI추천